Skip to main content
Premium Trial:

Request an Annual Quote

Ubiquitome, DKSH Sign Asia Pacific Distribution Agreement for Mobile COVID-19 Testing Platform

NEW YORK – Ubiquitome said on Monday that it has signed an exclusive agreement with Switzerland-based market expansion services group DiethelmKellerSiberHegner (DKSH) to market and sell Ubiquitome's mobile PCR-based COVID-19 testing platform Liberty16 in several countries in the Asia-Pacific region.

Under the terms of the deal, DKSH's Singapore-based technology business unit will provide marketing, sales, distribution, logistics, and after-sales services for the Liberty16 in Australia, Cambodia, Indonesia, Laos, Malaysia, Myanmar, New Zealand, the Philippines, Singapore, Thailand, and Vietnam. DKSH will also seek regulatory approval for the device in each of these markets, the company said.

Financial terms of the agreement were not disclosed.

The Liberty16 is a real-time PCR device that amplifies specific target DNA sequences to show the presence of any DNA of interest. It can run 16 tests at once, connects via Bluetooth to its own proprietary iPhone App, is battery-operated, and weighs 2.5 kg. Ubiquitome has suggested that the device's mobility makes it ideal to be used in places like airports to pre-screen international travelers for COVID-19.

Earlier this month, Ubiquitome said it had received NZ$528,927 ($324,388) from the government of New Zealand to help increase its manufacturing capacity for the Liberty16 in Auckland. The company said it also plans to apply for Emergency Use Authorization from the US Food and Drug Administration.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.